Kim Keene was not only a beloved artist, she was a mother and a business owner. She lost her battle with breast cancer, but her friends vow to carry on her mission of helping others.
As Enhertu’s reach continues to spread into additional forms of breast cancer, Daiichi Sankyo and AstraZeneca are ramping up ...
The Weiser Family Center for Breast Cancer will help improve experiences by creating programs to support patients and expand ...
Each year in October, the National Breast Cancer Awareness Month campaign helps to educate the public about symptoms, risk ...
Through communication and education, patients with metastatic breast cancer may be able to balance treatment with quality of ...
The ELECTRA trial found that the combination of elacestrant and abemaciclib was well-tolerated and showed promising clinical ...
If it can secure the funds, Oncolytics will advance the agent into a pivotal study, based on positive data from the Phase I BRACELET-1 trial.
In 2024, the Komen Financial Assistance program provided financial assistance totaling $1,257,750 to 2,267 people in Texas who are in breast cancer treatment or living with metastatic breast cancer.
Oncolytics Biotech (TSX:ONC) revealed results from its Phase 2 study evaluating its pelareorep-based therapy in patients with ...
Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...
The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback